Virucidal activity of Povidone-Iodine (PVP-I) have not yet been performed specifically on SARS-CoV-2. There in vitro studies demonstrating its effectiveness against multiple viruses including related coronaviruses. PVP-I could be effective to reduce viral load from asymptomatic COVID-19 patients and also provide a protective oropharyngeal hygiene measure for the health professionals.

On March 11, 2020, the World Health Organization recognized outbreak of disease COVID-19 (Coronavirus Disease 2019) and spread new coronavirus (SARS-CoV-2), which caused this disease, as a pandemic. The SARS-CoV-2 virus stimulates production antigen-specific antibodies for commercial tests have been developed. issue diagnosing to became especially acute together with beginning mass vaccination ...